Rates of peripheral arterial occlusive disease in patients with chronic myeloid leukemia in the chronic phase treated with imatinib, nilotinib, or non-tyrosine kinase therapy: a retrospective cohort analysis
Giles, F J, Mauro, M J, Hong, F, Ortmann, C-E, McNeill, C, Woodman, R C, Hochhaus, A, le Coutre, P D, Saglio, GVolume:
27
Language:
english
Journal:
Leukemia
DOI:
10.1038/leu.2013.69
Date:
June, 2013
File:
PDF, 253 KB
english, 2013